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Standardisation of spirometry
,
R. I. STEWART, E. BASSON
The suggested technical specifications in this document
apply to apparatus used by clipicians for the diagnosis of
common respiratory diseases and are to be considered as
the minimum acceptable standards. Specifications, features
and practices which are desirable, but not obligatory, are
also presented. It is accepted that a need exists for more
sophisticated apparatus for specialised indications (e.g. for
use in an academic institution for training or research, or
for standardisation of other respiratory equipment). For
sophisticated apparatus more stringent specifications a~ply,
some of which can be found in the original documents. -4
A. Apparatus
1. Spirometers should be able to measure volumes of at
least 7 litres with an accuracy of 3% or 50 ml, whichever
is the greater.
2. Spirometers should be capable of volume accumulation
for at least 30 seconds, time being measured with an
accuracy of 1%.
3. Flow should be measured with an accuracy of 5% of 0,2
lis between the ranges of 0 and 15 lis. Flow meters
should be linear within 25 or 50 mlls, whichever is the
greater. Baseline drift should be less than 50 ml/s.
4. The resistance of the spirometer or flow meter and
tubing system should be less than 0,1 kPa/lIs at a flow
of 15 lis; the inertia of the system should be less than
0,01 kPa/lIs.
5. Graphs of the flow-volume curve should be scaled with
a ratio of flow to volume at 2: 1 with 5 mm/I. Should
hand measurements be done on volume-time graphs,
then a minimum scale of 2 cm/s is required. When a
flow-volume loop or curve is plotted or displayed,
exhaled flow ~hould be plotted upwards and exhaled
volume towards the right.
The rationale for including these specifications takes into
account first of all the tolerance of the measuring equipment
and, secondly, expectation of the normal range of values
obtainable throughout the subject population. For example,
the recommendation that a spirometer should be capable of
measuring a vital capacity of 7 litres is based. on data .of
9347 coalminers of whom 95,25% had a forced VItal capacIty
(FVC) of less than 7,5 litres (Hankinson J, Petersen M, Am
Rev Respir Dis 1977, 115 (suppl 116)).
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Computer hardware
1. Analog-digital (A - D) converter should be a l2-bit
converter.
2. The data sampling rate should be at least 100 Hz.
3, The resolution of the electronic clock should be 40
microseconds.
Computer software
1. The manufacturers of microprocessor or computer-based
spirometry systems should provide som~ .explana~ory
data on the algorithms used in determmmg denved
values, especially if interpolation methods are required,
and in determining the start of test and end of the FVC
manoeuvre.
2. The source of reference values should be stated, together
with their scientific citation, and the user should be able"
to select or manually enter reference values best suited
to the healthy population from which subjects or patients
are likely to be drawn.
3. Should [he system offer a computerised interpretation,
the criteria for makirIg its diagnostic decisions should be
made available to the clinician if required.
4. It is desirable to display on the screen, and on the final
repon, both the volume-time and flow-volume recordings
of each succ~ssive attempt by the patient.
5. It is desirable to be able to select and combine expiratory
and inspiratory flow-volume data from different
manoeuvres.
6. A hard copy of the results must be provided by the
system.
7. It should be possible to store the data on removable
computer discs if the spirometer is connected to a
computer.
B. Calibration
All spirometers or spirometer systems must make provision
for an acceptable calibration routine which includes the
facility to adjust the calibration setting(s). The latter may
be different for inspiration and expiration, especially for
pneumotachometers. '.. .
Volume calibration should be performed by InJectmg
a known volume of air into the spirometer with a 3-litre
calibration syringe; the spirometer must record the calibra-
tion volume to within 3% or 50 ml, whichever is the
greater, under the appropriate conditions of temperature
and barometric pressure (i.e. ATPS). Calibration should be
performed at least 5 times across the fU.ll range ?fvolume
and flow of the spirometer at least dally, but It may be
necessary to calibrate 4-hourly (in epidemiological or indus-
trial surveys) if many tests are done in one day.
Flow is more difficult to calibrate; however, if the
spirometer is a flow-based spirometer, i.e. a pneumotacho-
meter or other flow meter is the primary measuring instru-
ment, then the injection of a known volume would ensure
calibration of volume, flow and time if the calibration
volume is recorded within 3%. The injection times should
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vary between 0,5 and 6,0 seconds for the 3-litre syringe so
as to ensure linearity over a wide range of flows. It is
important that the apparatus should be set to register
volumes at room temperature so that the recorded cali-
bration volume is expressed at ATPS, since room air is
injected. If the flow meter usually heats the gas to 37°C,
then the heating element should be switched off and allowed
to cool to room temperature prior to calibration. The
apparatus will need to be reset for measurements in a
patient, i.e. 37°C.
If flow is derived from differentiation of the volume
signal, then calibration of volume and time go a long way
towards ensuring accurate flow measurement. An additional
and desirable check on flow calibration is to integrate
(measure the area under) the flow-time curve generated by
injection of 3 litres; the volume thus derived should fall
between 2,95 and 3,05 litres.
The measurement of time is less easily calibrated. This
can be performed on recorders with an eleCtronic stopwatch,
and should be done at least every 3 months. (The mean of
10 measurements of 3 seconds should vary less than 5%, if
less than 0,15 seconds). A biological check, such as testing
a healthy subject with a known FEV!' is an alternative
option: this valu~ should vary less than 5% from one day to
the next in a healthy subject. .
Correction for BTPS: Measurements of volume could
be appreciably more accurate if ambient temperature and
barometric pressure are taken into account.
If volume or flow recorded from test subjects is not
measured at room or body temperature, as may be the case
with volume spirometers and unheated flow devices
positioned some distance from the mouth, the temperature
of the inhaled and exhaled gas should be measured. It is
desirable that the temperature should be measured with a
thermistor or thermocouple with a rapid response and
which has been calibrated against a mercury thermometer
between 20° and 37°C. This is essential for the appropriate
BTPS corrections to the raw data.
Comment:
1. Failure co correcc volumes for rhe appropriare BTPS faccor
would lead co an 8-10% error.
2. Dlfficulry wirh a calibrarion may indicare rhe need for rhe
appararus co be serviced.
3. We recommend rhar laboracories keep a logbook in which
calibrarion dara are enrered daily. .
c. Subject/patient manoeuvres
Should only expiratory volumes and/or flows be measured,
it is essential that a slow vital capacity (SVC) manoeuvre be
performed prior to the forced expiration. If both inspiratory
and expiratory FVC are measured in a single combined
manoeuvre, they should be performed in that order; the
inspiratory vital capacity, thus obtained, can be assumed to
be equal to the expired SVc. .
Comment. Ir is preferable co perform rhe forced inspira-
cory manoeuvre pn'or co rhe expiracory viral capaciry, since
rhis will reveal air rrapping due co dynamic collapse of
unsrable airways (in rhis case, expiracory FVC will be smaller
rhan rhe SVC or rhe inspirarory FVC).
The following procedure for the flow-volume curve is
recommended when both inspiratory and expiratory flows
are to be measured.
A period of quiet breathing is maintained until a constant
end-tidal volume is reached for three consecutive breaths.
The subject is then instructed to exhale slowly and maxi-
mally, to residual volume (RV) - the subject must be
actively encouraged to 'squeeze' out the last bit of air. Once
RV has been reached,-the subject is exhorted to inhale as
fast, forcefully and deeply as possible to total lung capacity
(TLC), to hold the inspiratory effort at TLC for 1 or 2
seconds, then to exhale as rapidly, forcefully, and completely
as possible for at least 6 seconds or until no more gas can
be exhaled. The manoeuvre with maximal effort, from
TLC to RV, is the expiratory FVC manoeuvre; and the
exhaled volume from RV to TLC is the inspiratory FVC.
A noseclip should preferably be worn by the subject,
particularly if the tidal volume flow-volume data is recorded.
The subject should preferably perform the test in the
sining position, but the standing position is acceptable for
children. The posture of the patient should be recorded on
the [mal report, as should the use of a noseclip.
Testing for bronchodilator responsiveness
Patients on bronchodilators should discontinue medication
prior to testing as follows: inhaled bronchodilator - 4
hours; theophyllin preparation - 12 hours; theophyllin
(slow release) - 24 hours. Baseline spirometry measure-
ments should include at leasr FVC and FEV l .
Procedure. An adequate dose of an inhaled p2-adrenergic
agonist should be administered. Inhalation of the aerosol
must be from functional residual capacity (FRC) to TLC
and inspiration should be held for 5-10 seconds before
exhalation.
The tests must be repeated at least 10 minutes after
administering the bronchodilator.
Criteria for a significant bronchodilator response.
The following are acceptable criteria: (a) an absolute increase
of > 200 ml in FEV] after administration of the broncho-
dilator; (b) an increase in FEV j of ~ 15% from baseline
FEV j ; (c) an increse in FEV j of> 7% of the mean of the
initial and the post-bronchodilator values may be used,
particularly in children.
Comment: In view of wide intra-parient variabiliry, PEFR
"!easurement is nor generally recommended for diagnosing
re:versible airflow obsrrucrion.
D. Recommended minimum measurements
The following are the minimum primary measurements
that must be recorded during forced spirometric manoeu-
vres: forced volume-time data: FVC and FEV]; flow-
volume curve: FVC, PEFR, PIFR, FEFso and FEV j • The
FEV j should be measUred simultaneously with. the flow-
volume data.
Comment: The FEFso refers co rhe insranraneous expira-
cory flow when 50% of rhe FVC has been exhaled.
It is desirable that the following measurements should
also be recorded during forced spirometric manoeuvres:
forced volume-time data: SVC and FEF25-75; flowvolume
curve: FIVC and FEF7s '
Comment: The FEF25- 75 is rhe average expiracory flow
over rhe middle parr of rhe FVC; FEF7S is rhe insrantaneousflow when 75% of rhe FVC has been exhaled.lr is preferable co
perform borh rhe SVC (or FIVC manoeuvre) and a FVC
manoeuvre because a difference berween rhe rwo may indicare
air rrapping; consequently rhe FEVjlFVC may be < FEV/
SVC (or FEV]IFIVC) and rherefore underesrimare rhe degree
of obsrrucrion.
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E. Criteria for an acceptable test
The criteria for an acceptable stan and end of test are best
assessed from the volume-time curve, while all other crireria
for acceprability are best evaluared from the flow-volume
curve.
1. Ideally, the scarl of lhe expiracory manoeuvre ('sran of
test') should be readily apparent from the volume-rime
recording: the initial segment of the expiratory curve
should have a very steep slope. The point from which
time is measured should be determined by the back-
extrapolation method, illustrated in Fig. 1. It is imponant
that the back-extrapolated volume be less than 10% of
. the FVC, or less than 0,1 litre, whichever is the greater;
if the extrapolated volume exceeds these limits, the
timed data should be disregarded. When the stan of tesr
is determined by computer, the zero time can be esti-
mated to coincide with the time determined by back-
extrapolation using the largest average volume v. time
slope which occurs over any 70 ms period. The scan of
inspiralion should be taken to occur when the inspiratory
flow exceeds 0,5 1/s.
The end of lhe forced expiracory reSl should usually
only occur after 6 seconds. It is considered to occur at
the time at which there has been less than 0,025 litre
change in volume over the previous 0,5 seconds, if the
forced expiratory time is less than 10 seconds, or less
than 0,04 litre change in the previous 2 seconds if the
forced expiratory time exceeds 10 seconds. Criteria for
the end offorced inspiralion have not yet been published,
but one method is to use the time at which the inspira-
tory flow falls below 0,5 1/s.
2. Peak expiratory flow (PEFR) should be produced within
the first 15 - 25% of the volume expired and the
ascending pan of the curve to peak flow should be as
steep as possible. The duration of the peak should be
less than 30 ms.
Comment: If lhe PEFR is nOl easily idenrified or is
delayed and reduced in amplirude lhis may indicare upper
airway obslrucrion or, more commonly, poor inilial effort.
In lhe former sicualion, lhe curve usually will be reprodu-
cible. If lhe lauer is lhe case, che curves are generally nOl
reproducible and inslanraneous flows al lower lung volumes,
and'even che FEVI' may be higher lhan on a reproducible,
lruly maximal expiracory flow-volume curve.
All curves in which peak flow is reached after the first
25% of the expired volume should be rejected if poor
effon is rhe cause.
3. The downslope of rhe curve should be smooth and free
of anefacts, such as coughing, mouthpiece or glottis
closure or second inspiration. Funhermore, the RV
should be reached by a gradual decrease in expiratory
flow rares toward zero.
Comment: A sudden reducrion of flow rares al lhe end
of lhe expiralion may be due co a submaximal efforl and
failure co exhale co RV. An erroneously smaller FVC due
co an incomplere expiralion will resull in facriliously high
FEFso and FEF75 values. Curves in which expiracory flow
suddenly decreases co zero should be accepced only if lhey
are reproducible; in lhis case, che phenomenon mighl indicace
chesl wall reslricrion.
4. The peak inspiratory flow (PIFR) should be reached
within the first 30 - 50% of the inspiratory volume and
the inspiratory curve is usually convex throughout.
F. Reproducibility
Reproducibility of the rests should be assessed both gra-
phically from superimposed flow-volume curves and from
the data.
1. The goal should be to register at least two flow-volume
curves that are virtually perfectly superimposable. With
regard to the actual data, the FVC and FEV 1.0 should be
reproducible to within 5% or 0,1 litre, whichever is the
greater; the instantaneous flow rates should be repro-
ducible to within 10%.
2. The FIVC and FIVo•s should also be reproducible to
within 5% or 0,1 litre, whichever is the greater, and the
PIFR within 10%.
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Fig. 1. Determination of 'zero-time': back-extrapolation method.
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3. A minimum of three and a maximum of eight attempts
should be made to achieve acceptable and reproducible
curves. If acceptable, reproducible curves are not
obtained, due to inability or lack of co-operation of the
subject, the test must be abandoned and repeated at a
later date.
Comment: le should be noced chac successively smaller
FEV 1•o and inscancaneous flow values may indicace disease,
e.g. excreme airway hyperreaccivicy or muscle facigue.
4. The final report should display the graphs that produce
evidence of the reproducibility of the test.
G. Selection of the best test
1. Curves and data must meet the requirements for both
acceptability and reproducibility.
2. Provided the above criteria are mer" the expiratory Cilrve
with the greatest sum of FVC + FEV1•o may be selected
and all (flow) measurements made from this curve.
Alternatively, the highest FEV 1•o· and FVC even from
different attempts, should be recorded. Similarly, the
inspiratory test with the greatest sum of FIVC and
FIVo.s should be selected for reponing.
3. The best expiratory and best inspiratory efforts may not
necessarily come from the same 'combined manoeuvre,
and therefore the best composite curve should be con-
structed.
H. Final report
1. The names of the patient, attending medical doctor and
operator of the spirometer must be stated together with
the date and time of the test. The position of the patient
while he/she performed the test should be recorded, as
should the use of a noseclip.
2. This should include the numerical data and graphic
presentation of the results. It is desirable that the graphs
be correctly scaled' and the orientation should be as
stated in section on Appararus. '
3. Evidence of the reproducibility of the final result must
be provided graphically or numerically (see section on
Reproducibility.)
4. Both patient and operator must see and sign the [mal
repon for tests with possible legal ramifications or which
may be used in disability assessment. The patient thereby
identifies the repon as referring to him/her and the
operator confirms that he/she assisted with'the test.
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